3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
66
Phase 2
53
Phase 1/2
28
Phase 3
16
Phase 2/3
3
Phase EARLY_PHASE1
1
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Pancreatic Neoplasms
6
Diffuse Intrinsic Pontine Glioma
2
Sarcoma
1
Pancreatic Adenocarcinoma
1
Neoplasms
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Lymphoma, B-Cell
1
Glioma
1
Bone Neoplasms
1
Interventions
Cyclophosphamide
5
Positron Emission Tomography Computed Tomography
4
pembrolizumab
3
Topotecan
2
Surveys and Questionnaires
2
Psilocybin
2
Midazolam
2
Methods
2
Ketoconazole
2
Ketamine
2
temsirolimus
1
posaconazole
1
poly ICLC
1
parathyroid hormone-related peptide (1-36)
1
lavender oil
1
jojoba wax
1
ginger extract
1
fluoromisonidazole
1
fludarabine phosphate
1
fludarabine
1
fluciclovine F-18
1
evolocumab
1
etoposide phosphate
1
beta-Glucans
1
Whole-Body Irradiation
1
Vincristine
1
Varenicline
1
Transplantation
1
Transcranial Direct Current Stimulation
1
Tetrahydrouridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Neoplasms
×
Gemcitabine
×
Clear all
NCT01713218
2012-10-24
NEOPACHI-001
Erasme University Hospital
Phase EARLY_PHASE1
Unknown
21 enrolled